Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of Therapeutics

Go back to Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of Therapeutics
(NASDAQ: VIR) Delayed: 42.21 +2.66 (6.73%)
Previous Close $39.55    52 Week High
Open $39.95    52 Week Low
Day High $42.88    P/E N/A 
Day Low $39.95    EPS
Volume 556,100